Lindsay Engle reviews the status quo of cannabis on the East Coast, where a number of states appear to have recreational legalization on the horizon.
Canopy Growth is as close to a global “blue-chip” cannabis stock as they come. But what is the now multi-billion dollar market cap cannabis company about?
In part 3 of the series, Naiberg tackles plant breeders’ rights and how cannabis breeders in Canada could protect new plant varieties.
Marguerite Arnold lists some of the notable figures disrupting the European cannabis space.
There are a number of options to explore when considering environmental monitoring for your cannabis cultivation facility.
We sit down with speakers from an upcoming panel at the California Cannabis Business Conference to hear what issues distribution companies are facing.
In Part 2 of the series, Naiberg discusses how cannabis business owners can protect new technologies and inventions through applying for a patent.
Richard Naiberg starts his series of articles with an in-depth look at how cannabis businesses should protect trade secrets.
State regulators sent a cease-and-desist letter to Good Chemistry for using pesticides, while the company claims they told the state they were using safe pesticides even before starting business in Massachusetts.
Health Canada, the Canadian military, sports organizations and provincial governments continue to issue (and revise) guidelines as the October market start looms.
